Pasadena, United States
Replenish, Inc. is a biotechnology startup founded in 2007 that has made significant strides in the healthcare industry. The company has developed the MicroPump, the world's smallest implantable, refillable drug pump tailored for the $7 billion retinal therapeutic market. Currently undergoing clinical investigation, the MicroPump aims to cater to patients with age-related macular degeneration (AMD) by delivering sight-saving medication. Following a swift 20-minute outpatient surgical procedure, the pump is wirelessly programmed, recharged, and refilled by physicians every 6 months, providing the convenience of biotech protein therapies that would otherwise necessitate weekly administrations via a physician's syringe for life.
Despite not yet being FDA-approved for sale, Replenish, Inc.'s innovation holds promise in revolutionizing treatment methodologies in the biotechnology and healthcare sectors. The company secured a substantial $10.25M Venture Round investment on 15 July 2009. Although the details of the investors are not specified, this investment signifies a strong endorsement of the potential of the MicroPump and Replenish, Inc.'s capabilities in addressing critical medical needs. With its headquarters in the United States, Replenish, Inc. has positioned itself as a key player in driving advancements in retinal therapeutics and biotechnology.
For more information, visit their website at www.replenishinc.com.
